A systems biology approach to the effect of aging, immunosenescence and vaccine response.

February 19, 2018 at 9:12 am

Current Opinion in Immunology August 2014 V.29 P.62-8.

Poland GA1, Ovsyannikova IG2, Kennedy RB2, Lambert ND2, Kirkland JL3.

Author information

1 Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: poland.gregory@mayo.edu.

2 Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.

3 Robert & Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.

Abstract

Aging can lead to immunosenescence, which dramatically impairs the hosts’ ability to develop protective immune responses to vaccine antigens. Reasons for this are not well understood.

This topic’s importance is reflected in the increases in morbidity and mortality due to infectious diseases among elderly persons, a population growing in size globally, and the significantly lower adaptive immune responses generated to vaccines in this population.

Here, we endeavor to summarize the existing data on the genetic and immunologic correlates of immunosenescence with respect to vaccine response.

We cover how the application of systems biology can advance our understanding of vaccine immunosenescence, with a view toward how such information could lead to strategies to overcome the lower immunogenicity of vaccines in the elderly.

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119552/pdf/nihms589246.pdf

Advertisements

Entry filed under: Antimicrobianos, Bacterias, HIC no SIDA, Infecciones en seniles, Inmunizaciones, Metodos diagnosticos, REPORTS, Sepsis, Update.

The microbiota and microbiome in aging: potential implications in health and age-related diseases. Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects


Calendar

February 2018
M T W T F S S
« Jan   Mar »
 1234
567891011
12131415161718
19202122232425
262728  

Most Recent Posts


%d bloggers like this: